1255055002: Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Virtual therapeutic moiety\Vedolizumab\Product containing only vedolizumab in parenteral dose form (medicinal product form)\Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug)

\Medicinal product\Medicinal product categorized by disposition\Product containing selective adhesion molecule inhibitor\Product containing alpha-4 integrin receptor antagonist\Product containing vedolizumab\Product containing vedolizumab in parenteral dose form (medicinal product form)\Product containing only vedolizumab in parenteral dose form (medicinal product form)\Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug)
\Medicinal product\Medicinal product categorized by disposition\Product containing selective adhesion molecule inhibitor\Product containing alpha-4 integrin receptor antagonist\Product containing vedolizumab\Vedolizumab\Product containing only vedolizumab in parenteral dose form (medicinal product form)\Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing vedolizumab\Product containing vedolizumab in parenteral dose form (medicinal product form)\Product containing only vedolizumab in parenteral dose form (medicinal product form)\Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing vedolizumab\Vedolizumab\Product containing only vedolizumab in parenteral dose form (medicinal product form)\Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Product containing vedolizumab\Product containing vedolizumab in parenteral dose form (medicinal product form)\Product containing only vedolizumab in parenteral dose form (medicinal product form)\Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Product containing vedolizumab\Vedolizumab\Product containing only vedolizumab in parenteral dose form (medicinal product form)\Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug)
\Medicinal product\Product manufactured as parenteral dose form\Product containing vedolizumab in parenteral dose form (medicinal product form)\Product containing only vedolizumab in parenteral dose form (medicinal product form)\Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Oct 2022. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

5144259015 Vedolizumab 300 mg powder for solution for infusion vial en Synonym Active Entire term case insensitive SNOMED CT core module

5144260013 Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	Is a	Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)	true	Inferred relationship	Existential restriction modifier
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	Has manufactured dose form	Powder for conventional release solution for infusion	true	Inferred relationship	Existential restriction modifier
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	Has unit of presentation	Vial	true	Inferred relationship	Existential restriction modifier
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	Has precise active ingredient	Vedolizumab	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	Has basis of strength substance	Vedolizumab	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	Has presentation strength numerator unit	milligram	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	Has presentation strength denominator unit	Vial	true	Inferred relationship	Existential restriction modifier	1

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
5144259015	Vedolizumab 300 mg powder for solution for infusion vial	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module
5144260013	Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module